Roflumilast Tablets (VA-27-00006601)
Veterans Affairs · NAC PHARMACEUTICALS (36E797)
Capture briefs (a one-page, shareable copy of this page) are part of Pro. The CSV here holds the notice, its timeline and past awards.
Where this opportunity stands
Every notice posted under solicitation 36E79726Q0005 in this department, oldest first.
- Sep 9, 2026 · this noticeSources Sought
Next steps for this stage
Standard steps for the notice type; not advice about this buyer.
- Answer the notice: this is when the requirement can still be shaped.
- Contact the contracting officer named on the notice.
- Check who won similar work; they are the likely bidders.
What the notice says
I am conducting market research for the procurement of Roflumilast Tablets, for the Department of Veterans Affairs (VA), Department of Defense (DoD), Indian Health Service (IHS), Bureau of Prisons (BOP), and Federal Health Care Center (FHCC). This procurement will result in national mandatory requirements contract for the above agencies. Other companies with the same/similar product will be blocked out for ordering; therefore it is our goal to award lower than FSS/Open Market prices on the resultant national contract based on purchases of a committed volume. These products will be awarded in t… (show all)
he aggregate for all strengths and sizes for the base year and all option years included in the solicitation. Please provide a response to the following: Is your Company able to meet the following minimum requirements: National Drug Code (NDC): Offerors shall provide a separate and distinct eleven-digit NDC number unique to the offeror (e.g., 00012-3456-78) for each product proposed. The first five numbers of the eleven-digit NDC number for each product proposed shall identify the offeror. Additionally, the successful offeror/contractor�s label with its unique NDC shall be the only label on the product. Contractors shall not affix their label over another label on the product. Does your company have a unique NDC (Labeler Code)?_____________ If the offeror is not the manufacturer of the offered items, the offeror shall submit a letter of commitment from the manufacturer to the offeror which will assure the offeror a source of supply sufficient to satisfy the Government's requirements for the contract period. Name of Manufacturer: _________________ Would you be able to provide a letter of commitment from the manufacturer of the offered drug? _____________ Pharmaceutical Prime Vendor: All Ordering Activities under the Department of Veterans Affairs and Department of Defense acquire their pharmaceutical requirements through their Pharmaceutical Prime Vendor Program (PPV). The contractor shall ensure that chargeback agreements with the PPVs have been executed with sufficient time to permit the PPVs to begin timely distribution of Government orders, if an award is made. Does your company currently have a business-to-business agreement with the PPVs?_________ Under NAICS code 325412, is your company size (check one): Large Business ______ Small Business ______ If a small business, does your company manufacture (measure, weigh, mix, and compound) at least 50% of the product offered?_________ Is the offered end product U.S-made or an end product of a Trade Agreements Act designated country?_________ Can your company meet the following product, bottle size and usage? Please indicate any details or comments. ___________________________________________________________ ___________________________________________________________
Who won similar work
79 award notices on SAM.gov in the last 24 months. Match: Same office, same NAICS 325412.
| Winner | Awards | Value | Last |
|---|---|---|---|
| GOLDEN STATE MEDICAL SUPPLY, INC. | 26 | $320.5M | Sep 15, 2026 |
| EXELAN PHARMACEUTICALS INC | 7 | $209.8M | Mar 5, 2026 |
| XLCARE PHARMACEUTICALS INC | 6 | $144.4M | Mar 9, 2026 |
| AVKARE LLC | 6 | $134.0M | Jul 22, 2026 |
| RADHA PHARMACEUTICALS INC | 6 | $69.3M | Apr 17, 2026 |
| PFIZER INC · $PFE | 2 | $120.9M | Apr 29, 2025 |
| SEQIRUS USA INC | 2 | $82.6M | Dec 15, 2025 |
| DR REDDY'S LABORATORIES, INC. · $RDY | 2 | $38.9M | Jan 9, 2026 |
| SOLCO HEALTHCARE US LLC | 2 | $21.5M | Jun 18, 2026 |
| MARLEX PHARMACEUTICALS INC | 2 | $10.3M | May 22, 2026 |
Value counts single-winner awards. "Shared" awards are multiple-award contracts that list every winner with the same total ceiling; that ceiling is not one company's win, so it is not added in.
- Sep 15, 2026GOLDEN STATE MEDICAL SUPPLY, INC.$26.6M6505--Mesalamine 1200mg Tablet (VA-27-00000768)
- Aug 26, 2026GOLDEN STATE MEDICAL SUPPLY, INC.$10.8M6505--Diltiazem SA Capsules (AB3)
- Aug 19, 2026GOLDEN STATE MEDICAL SUPPLY, INC.$9.6M6505--Esomeprazole Magnesium Capsules Effective 10/19/2026 - 10/18/2027
- Jul 24, 2026MYLAN PHARMACEUTICALS INC$436.5M6505--Budesonide/Formoterol INH
- Jul 22, 2026AVKARE LLC$1.9M6505--Famciclovir Tablets
- Jul 22, 2026ANIP ACQUISITION CO BAUDETTE 56623$3.7M6505--Benazepril HCL Tablets
- Jun 25, 2026PURACAP LABORATORIES LLC$32.4M6505--PuraCap Contract Award Venlafaxine 24HR SA Capsules
- Jun 18, 2026SOLCO HEALTHCARE US LLC$8.6M6505--Ropinirole HCL Tablets 9/28/2026 - 9/27/2027
- May 22, 2026MARLEX PHARMACEUTICALS INC$5.9M6505--Melatonin Tablets Effective 09/15/26 - 09/14/27
- May 19, 2026AVKARE LLC$2.0M6505--Montelukast NA Chewable Tablets Effective August 09, 2026 to August 08, 2027
Competitive landscape
For the 8 most frequent past winners above. Lobbying is matched by the company's exact name or exact ticker; agencies are as named on the filings.
- 0 of these past winners lobbied Veterans Affairs, Dept of (VA) since 2024 (0 filings)
- 0 of their lobbyists list a past Veterans Affairs, Dept of (VA) job
- $61K from their corporate PACs since 2024 to members of House Committee on Appropriations, House Committee on Veterans' Affairs, Senate Committee on Appropriations, Senate Committee on Veterans' Affairs
- 0 foreign-agent (FARA) registrations
Policy around it
Bills the past winners named while lobbying this agency's issues, rules from the department, and executive orders that name the agency, last 12 months.
- 0 bills named on the past winners' lobbying filings
- 25 rules from the department in the last 12 months
- 0 executive orders naming the agency in the last 12 months
Market
For past winners matched exactly to a listed company. Insider trades are open-market buys and sells (Form 4) in the last 90 days, shown as facts; our own study found insiders do not reliably buy ahead of awards.
- 2 of the past winners are listed companies
- 3 insider buys and 1 insider sells at them in the last 90 days
Sources: SAM.gov notices and award notices; Senate LDA lobbying filings; FEC filings; FARA; Federal Register; congress.gov; SEC Form 4. Every row above links to its record.
Companies are matched to tickers by exact name only. A company we could not match shows no market rows; that is a miss, not a finding.